Background Community transmission of coronavirus 2019 (Covid-19) was detected in the
state of Washington in February 2020. Methods We identified patients from nine Seattle-area …

Detection of SARS-CoV-2 with a CRISPR-Based Test A new method for the detection of
SARS-CoV-2 combines simplified extraction of RNA with isothermal amplification and CRISPR (…

The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies on …

Nearly 400,000 people worldwide are known to have been infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) beginning in December 2019. The virus has …

Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and …

Objective Our objective was to test whether natalizumab, an antibody against very late
activating antigen (VLA)‐4, interferes with central nervous system immune surveillance as …

The novel coronavirus SARS-CoV-2 was first detected in the Pacific Northwest region of the
United States in January 2020, with subsequent COVID-19 outbreaks detected in all 50 …

After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …

The recent outbreak of the novel coronavirus SARS-CoV-2, which causes COVID-19, can be
diagnosed using RT-qPCR, but inadequate access to reagents and equipment has slowed …

Despite limited genomic diversity, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has shown a wide range of clinical manifestations in different patient populations. …